Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Randomized Clinical Trial of Intravitreal dexamethasOne Versus Bevacizumab in Aboriginal and Torres Strait Islander patientS With Diabetic Macular Oedema (The OASIS Study)

NCT04619303 is registered in ClinicalTrials.gov with Lions Eye Institute, Perth, Western Australia as lead sponsor.

NCT NCT04619303
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04619303 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Randomized Clinical Trial of Intravitreal dexamethasOne Versus Bevacizumab in Aboriginal and Torres Strait Islander patientS With Diabetic Macular Oedema (The OASIS Study)
Lead sponsor
Lions Eye Institute, Perth, Western Australia
Phase
Phase 4
Overall status
Completed
Start date
February 7, 2017
Completion date
February 14, 2020
Enrollment
59 (actual)
Sites
13

Conditions

As the registry lists them; a condition with its own page is linked.

diabetic macular edema, diabetic retinopathy